February 6, 2019

Improving Alzheimer’s Disease Management: Early Diagnosis and Health Equity Considerations

Hybrid 2021 Alzheimer’s Association International Conference (AAIC)

Panel Discussion: Case Study

In this section, the panel discusses a patient case study in the context of the AD diagnostic journey, from the initial presentation at the clinic to diagnosis and management. Dr. Sabbagh frames the case study within the conceptual framework, with Dr. Woo and Professor Blennow providing expert perspectives on the clinical assessment findings and biomarker results, respectively, before a diagnosis for the patient is considered. The symposium closes with a brief discussion of the key considerations for disclosing an early diagnosis of AD.

Key Learning Objectives from Biogen’s AAIC 2021 Symposium:

  • Highlight the importance of early detection and diagnosis of AD, through appropriate use of cognitive and functional screening tools and biomarker assessments
  • Assess current healthcare system readiness for a paradigm shift to early diagnosis of AD
  • Outline considerations in patient care for underrepresented and underserved populations

Disclosure: All panelists received honoraria from Biogen for participation in this symposium.

Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.